Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Published on 17/01/202517/01/2025 by Research Hypothesis

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Prof Hiranmoy Das, Texas Tech University Health Sciences Center, United States

Prof. Hiranmoy Das, MSc, PhD, FAHA, is a renowned biochemist and pharmacologist with a distinguished career. He holds a Ph.D. from the University of Calcutta and has postdoctoral training from prestigious institutions like Harvard Medical School and the Hyogo Institute of Clinical Research. Currently a Professor at Texas Tech University, his research focuses on cardiovascular stem cell therapies, regenerative medicine, and immunology. He has received numerous awards, including induction into the National Academy of Inventors and the American Heart Association. Prof. Das has authored several publications and holds multiple patents. 🌟📚💉🔬🧬

Publication Profile

Google Scholar

Education

Prof. Hiranmoy Das holds a Ph.D. in Biochemistry from the University of Calcutta (1995) and has extensive academic training in zoology, advanced cytogenetics, immunology, and biology. He completed postdoctoral fellowships at prestigious institutions, including Harvard Medical School (1999-2002) and Hyogo Institute of Clinical Research, Japan (1996-1999). Prof. Das has held prominent roles, such as Professor at Texas Tech University (2016-present) and Associate Professor at The Ohio State University (2008-2016). He also directed cardiovascular stem cell research laboratories. His remarkable career spans over decades, focusing on innovative research in the fields of biochemistry and immunology. 📚💉🔬

Honors and Awards

Prof. Hiranmoy Das, a distinguished researcher and educator, has received numerous accolades for his groundbreaking contributions. In 2024, he was elected as a Fellow of the National Academy of Inventors. He was inducted into the prestigious Sigma Xi in 2023 and awarded the President’s Excellence in Research Award in 2022. As a tenured professor at Texas Tech University, he earned the Chancellor’s Council Distinguished Research Award in 2021. His honors also include the American Heart Association Fellowship (2021) and a Keynote Speaker role at an International Conference in 2018. Earlier awards include the NIH K01 Award and National Merit Scholarship. 🏆🔬🎓

Experiences

Prof. Hiranmoy Das has taught a variety of undergraduate, graduate, and professional courses at TTUHSC, including leadership roles in Pharmaceutical Sciences Research (G) in Spring, Summer, and Fall sessions from 2021 to 2024 📚. He led courses like Clinical Correlation-6 and Integrated Therapy and Practice VII, as well as Experimental Design and Biostatistics 🧪. Prof. Das has mentored students in clinical and research settings, contributing significantly to pharmaceutical education 💡. His commitment to fostering academic growth is reflected in his continued leadership in research-focused courses, impacting future professionals in the field of pharmaceutical sciences 🎓.

PhD Thesis

Prof. Hiranmoy Das appears to be heavily involved in mentoring and advising graduate students, particularly in the fields related to pharmacy, veterinary medicine, and health sciences. His research likely focuses on advanced pharmaceutical sciences, drug development, and therapeutics. With his role in advising students pursuing PhD and MS theses, his research could be centered around pharmaceutical applications, medicinal chemistry, or pharmacology. Given his involvement in both veterinary and pharmacy programs, his research may also bridge the gap between human and veterinary health, focusing on biomedical sciences, drug formulations, and therapeutics for both sectors. 📚💊🐾👩‍🔬👨‍🔬

Research Focus

Hiranmoy Das focuses on molecular and cellular biology, particularly related to vascular biology, immunology, and inflammation. His research delves into the roles of Kruppel-like factor 2 (KLF2) in endothelial cells, immune responses, and its regulatory functions in cardiovascular health. He also investigates autophagy, cell death, and ischemic stroke therapies, emphasizing the use of assays for monitoring these processes. His work highlights the role of phytochemicals in cancer prevention and the immune system’s effector functions. Das has made significant contributions to understanding cellular signaling and disease mechanisms, with implications for therapeutic development. 🔬💉🧬🫀

Publication Profile

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Current advances in ischemic stroke research and therapies

MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

CD1-mediated γ/δ T cell maturation of dendritic cells

Mengmeng Liu | Biology and Life Sciences | Best Researcher Award

Published on 14/12/202414/12/2024 by Research Hypothesis

Mengmeng Liu | Biology and Life Sciences | Best Researcher Award

Ms Mengmeng Liu, Shandong University, China

Mengmeng Liu, Ph.D. 🎓, is a postdoctoral researcher at Shandong University’s State Key Laboratory of Microbial Technology, mentored by Prof. Qingsheng Qi. 🌱🧬 She earned her Ph.D. in Biochemistry and Molecular Biology from the Kunming Institute of Botany, CAS, and a B.Sc. in Biotechnology from Jilin University. Her research focuses on metabolic engineering of Yarrowia lipolytica for sustainable β-carotene and terpene production 🌿🧪, employing NHEJ-mediated mutagenesis and high-throughput screening. Proficient in advanced genetic, molecular biology, and analytical techniques 🔬💻, she has published extensively in high-impact journals and holds patents in microbial biotechnology. 📜⚗️

Publication Profile

Orcid

Education and Experience

Ms. Mengmeng Liu is a dedicated researcher in microbiology and biochemistry. She has been a postdoctoral fellow at the State Key Laboratory of Microbial Technology, Shandong University, under Prof. Qingsheng Qi since September 2019 🧬📚. She earned her Ph.D. in Biochemistry and Molecular Biology from the Kunming Institute of Botany, Chinese Academy of Sciences, under Prof. Junchao Huang in 2019 🌱🔬. Ms. Liu completed her Bachelor’s degree in Biotechnology (Plant Sciences) from Jilin University in 2013 🎓🌿. Her academic journey highlights her commitment to advancing knowledge in microbial and plant biotechnology, contributing to impactful research in these fields. 🌟🧪

Research direction

Mengmeng Liu is a postdoctoral researcher focusing on designing and constructing Yarrowia lipolytica cell factories. Using traditional and cell morphology metabolic engineering, she optimizes yeast metabolism for the green bioproduction of terpenoids like β-carotene using inexpensive substrates. She explores the application of non-homologous end joining (NHEJ) in metabolic engineering of Y. lipolytica, develops methods for mutant library construction, and establishes high-throughput screening for terpenoid compounds. During her Ph.D., Mengmeng worked on designing Shewanella oneidensis cell factories for producing terpenoid compounds (like lutein and astaxanthin) using cheap industrial byproducts. She also contributed to constructing and modifying metabolic pathways in marine microalgae.📦🔬🚀

Representative papers

Mengmeng Liu is an accomplished researcher focused on metabolic and morphological engineering of microbial strains. Her work includes optimizing β-carotene production in Yarrowia lipolytica and mapping nonhomologous end joining-mediated integration for genome-scale mutagenesis. Liu has also explored the high-throughput screening of gene targets for enhancing carotenoid production in oleaginous yeast. Additionally, her research extends to engineering Sphingobium sp. to accumulate various carotenoids using agro-industrial byproducts, and enhancing coproduction of cell-bound zeaxanthin and exopolysaccharides through metabolic engineering. 🌱🔬📊

Research Focus

Mengmeng Liu’s research focuses on genetic and metabolic engineering of Yarrowia lipolytica, an unconventional yeast, for biotechnological applications. Her work includes the development of genetic markers, genome-scale trackable mutagenesis, and efficient production of important compounds like 2′-fucosyllactose and β-carotene. She applies high-throughput screening techniques like flow cytometry to enhance yield and optimize metabolic pathways. Her studies aim to improve the strain’s productivity and sustainability for industrial applications using agro-industrial byproducts and by manipulating cellular processes. 🌱🔍🧬

Publication Top Notes

Development of genetic markers in Yarrowia lipolytica

Efficient production of 2′-fucosyllactose in unconventional yeast Yarrowia lipolytica

Mapping of Nonhomologous End Joining-Mediated Integration Facilitates Genome-Scale Trackable Mutagenesis in Yarrowia lipolytica

Rapid Gene Target Tracking for Enhancing b-Carotene Production Using Flow Cytometry-Based High-Throughput Screening in Yarrowia lipolytica

Engineering Sphingobium sp. to Accumulate Various Carotenoids Using Agro-Industrial Byproducts

Morphological and Metabolic Engineering of Yarrowia lipolytica to Increase β-Carotene Production

Enhanced Coproduction of Cell-Bound Zeaxanthin and Secreted Exopolysaccharides by Sphingobium sp. via Metabolic Engineering and Optimized Fermentation

Illustrating and enhancing the biosynthesis of astaxanthin and docosahexaenoic acid in Aurantiochytrium sp. SK4

Conclusion

Mengmeng Liu’s research is characterized by innovation, interdisciplinary collaboration, and a commitment to sustainable biotechnological solutions. Her outstanding achievements in metabolic engineering, impactful publications, and practical innovations position her as an exemplary candidate for the Best Researcher Award. 🌱📚 Her work embodies the spirit of pushing boundaries and advancing knowledge in the field, making significant contributions to sustainable biotechnology. 🚀🌍

Mohamed Houta | Biology and Life Sciences | Best Researcher Award

Published on 31/07/202431/07/2024 by Research Hypothesis

Mohamed Houta | Biology and Life Sciences | Best Researcher Award

Mr Mohamed Houta, Beni Suef University, Egypt

Mohamed Houta appears to be a strong candidate for the Research for Best Researcher Award based on his extensive experience and contributions in the field of vaccinology, particularly related to poultry diseases

publication profile

google scholar

Solid Background in Immunology and Vaccinology

Mohamed has a robust foundation in immunology and vaccine research, which is evident from his current role as a Scientific Affairs Manager at Klybeck Life Sciences and his prior experience at MEVAC for Vaccines. His focus on inactivated and live poultry vaccines, conducting preclinical and clinical trials, and ensuring regulatory compliance underscores his deep expertise.

Significant Research Contributions

His publication record highlights his research impact. For example, his work on the Emergence, Evolution, and Spread of Infectious Bronchitis Virus Genotype GI-23 published in Archives of Virology and Phylodynamic and Recombination Analyses published in Animals demonstrate his ability to conduct significant and relevant research. These studies have contributed to a better understanding of avian diseases, which is critical for advancing vaccine development.

Leadership in R&D

As a Scientific Affairs Manager, Mohamed has demonstrated leadership in research and development, particularly in vaccine design and production, including the implementation of complex R&D projects and ensuring compliance with European and Saudi regulations. His involvement in reviewing and approving the development and validation of analytical methods and in vivo vaccine testing protocols indicates a strong leadership role in research.

Ongoing Academic Pursuits

Mohamed is also pursuing a PhD in Veterinary Sciences with a focus on poultry diseases at Beni Suef University and Padua University, which further strengthens his qualifications as a researcher committed to advancing knowledge in his field.

Global Perspective

His involvement in research and clinical trials across different countries and his multilingual abilities (Arabic, English, and Italian) add a global perspective to his work, which is valuable in the context of a global award.

Conclusion

Given Mohamed Houta’s extensive research contributions, leadership in R&D, and ongoing academic pursuits, he is a suitable candidate for the Research for Best Researcher Award. His work not only advances public health through vaccine development but also contributes significantly to the global understanding of avian diseases.

Publication top notes

The emergence, evolution and spread of infectious bronchitis virus genotype GI-23

Phylodynamic and recombination analyses of avian infectious bronchitis GI-23 reveal a widespread recombinant cluster and new among-countries linkages

COVID-19: Risk assessment and mitigation measures in healthcare and non-healthcare workplaces

Infection with Avian Coronaviruses: A recurring problem in turkeys

Dall’Est all’Ovest: ricostruzione filodinamica della storia della variante 2 del virus della bronchite infettiva aviare

Iwona Golonka | Biology and Life Sciences | Hypothesis Achievement Award

Published on 24/07/202424/07/2024 by Research Hypothesis

Iwona Golonka | Biology and Life Sciences | Hypothesis Achievement Award

Dr Iwona Golonka, Department of Physical Chemistry and Biophysics Pharmaceutical Faculty Wroclaw Medical University, Poland

Iwona Maria Golonka is an assistant professor at Wroclaw Medical University, specializing in Physical Chemistry and Biophysics. She earned her Ph.D. in Chemical Sciences from the University of Wrocław and holds a Master’s degree in Chemistry. With over 15 impactful publications and a research focus on antimicrobial peptides and advanced pharmaceutical methods, her work includes significant national and international collaborations. Notable achievements include awards for her research in antimicrobial compounds and patents for innovative drug delivery methods. She has also contributed to academic lectures and conferences globally. 🧪📚🏅

Publication profile

Orcid

Education

Dr. Iwona Golonka has been an Assistant Professor at Wroclaw Medical University’s Faculty of Pharmacy since 2003, specializing in Physical Chemistry and Biophysics. With 15 scientific papers boasting a total Impact Factor of 48.378, including a notable 2020 publication with an IF of 9.381, Dr. [Name] has significantly contributed to the field. They also co-authored a script for pharmacy and medical analytics students. Dr. [Name] earned their Ph.D. in Chemical Sciences from the University of Wrocław in 2006, with a focus on coordination chemistry, following a Master’s degree in Chemistry in 1999. 🧪📚🔬

Presentations

Golonka I. has contributed significantly to the field of chemistry through various presentations. At the Chemistry towards Biology 10 conference in Bratislava (2022), she explored peptide stability in monolayers and Langmuir balance applications in pharmaceutical sciences. Earlier, at the Fifth Informal Conference on Reaction Kinetics and Atmosphere Chemistry (2004), she studied the reactions of nitrogen dioxide with propanols and fluorinated derivatives. Her research on EPR characteristics of metal complexes was presented at the 9th Nordic IHSS Symposium (2003), and she investigated the impact of metal ions on free radicals in humic brown coal at ISEB 15 (2001). 🌟🔬📊

Awards

In 2022, the Rector of the Medical University of Gdańsk awarded a diploma for scientific and team achievements of the 1st degree for the synthesis and assessment of new antimicrobial compounds and fluorescent dyes. Individual awards of II degree were received in 2021, 2020, and 2022 for publications in the JCR database. In 2016, received a 1st degree Team Award for work on physicochemical methods in drug development and a distinction in the Eureka! MZD competition for inventing a flotation tablet. Previous accolades include the 2004 Dr. Emil Niedźwirski Scholarship and multiple team awards in 2007, 2010, and 2016. 🏆📜🔬💡

Research focus

Iwona Golonka’s research focuses on the stability and effectiveness of peptides and antioxidants in various matrices. Her work includes evaluating the decay kinetics of antioxidants in black elderberry, studying the impact of peptides on monolayers, and analyzing peptide stability. Key studies involve examining how newly synthesized peptides affect monolayer stability and antibacterial properties. Golonka’s contributions also cover antioxidant properties in cellulose matrices and interactions with phosphatidylinositol monolayers. Her research integrates aspects of biochemistry and material science, aiming to enhance the understanding and application of peptides and antioxidants in health and industry. 🧬🔬🍇